US Federal 2025-2026 Regular Session

US Federal Senate Bill SB2353

Introduced
 
Introduced
7/17/25  

Caption

Microplastics Safety Act

Summary

The Microplastics Safety Act would direct the Secretary of Health and Human Services, acting through the FDA Commissioner, to conduct a study on the human health impacts of exposure to microplastics in food and water. The study must identify major exposure pathways and examine effects on children’s health, the endocrine system, cancer, chronic illness, reproductive health, and any other areas the Secretary considers important. Within one year of enactment, HHS would have to submit a report to Congress summarizing the study’s findings and conclusions and offering recommendations for legislative or administrative action. The bill is primarily a research-and-reporting measure; it does not itself establish new regulatory limits on microplastics or directly change food or water safety standards.

Impact

If enacted, the bill would add a new federal research mandate for HHS/FDA focused on microplastics in food and water and would require a congressional report with policy recommendations. It would not directly amend existing statutes or create immediate compliance obligations for regulated parties, but it could lay the groundwork for future FDA, HHS, or congressional action affecting food safety, drinking water, consumer products, and environmental health policy.

Sentiment

The available context suggests generally favorable or at least noncontroversial treatment of the bill. It was introduced by Senators Merkley and Scott of Florida and referred to the Senate Committee on Health, Education, Labor, and Pensions, with no recorded votes or committee debate in the provided materials. The bipartisan sponsorship and the bill’s study-oriented approach indicate a measured, public-health-focused sentiment rather than a sharply partisan one.

Contention

No specific points of contention appear in the provided record because there are no committee transcripts or votes. Potential areas of debate, if the bill advances, could include whether FDA/HHS should prioritize microplastics research over other health issues, how broadly to define health impacts, and whether the resulting report should lead to regulation of food, water, or consumer products. At this stage, however, no opposing viewpoints are documented.

Companion Bills

US HB4486

Same As Microplastics Safety Act

Similar Bills

No similar bills found.